Product image of Kenalog (Triamcinolone Acetonide) supplied by GNH India

Kenalog

Active Ingredient:
Triamcinolone Acetonide
Origin:
EU

Kenalog (Triamcinolone Acetonide)

Triamcinolone Acetonide, the active ingredient in Kenalog, is a corticosteroid presented as an injectable suspension for intra‑articular and intramuscular use. It reduces inflammation and modulates immune responses in patients requiring local or systemic corticosteroid therapy.

GNH India supplies Kenalog as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kenalog (triamcinolone acetonide) is employed in the management of inflammatory and immune‑mediated conditions affecting joints, soft tissues and allergic responses.

  • Rheumatoid arthritis (intra‑articular): provides rapid reduction of joint swelling and pain.
  • Osteoarthritis (intra‑articular): improves joint function and decreases discomfort.
  • Bursitis and tendinitis (injection): alleviates localized inflammation and promotes recovery.
  • Severe allergic reactions (systemic injection): suppresses acute hypersensitivity and airway edema.
  • Dermatologic inflammatory disorders (intralesional): reduces lesion size and erythema.

How It Works

  • Triamcinolone acetonide binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and alters gene transcription. This interaction down‑regulates pro‑inflammatory cytokines, inhibits phospholipase A2 activity, and reduces leukocyte migration, resulting in potent anti‑inflammatory and immunosuppressive effects at the site of administration.

Side Effects

Kenalog may cause a range of adverse reactions, from mild to severe, depending on dose, route and patient susceptibility.

Common Side Effects

  • Injection site pain or irritation.
  • Transient flushing or warmth.
  • Mild headache.
  • Elevated blood glucose in diabetic patients.
  • Temporary increase in blood pressure.
  • Minor gastrointestinal discomfort.

Serious or Rare Side Effects

  • Severe allergic reaction (anaphylaxis).
  • Significant adrenal suppression.
  • Osteonecrosis of the jaw.
  • Opportunistic infections.
  • Vision changes or cataract formation.
  • Tissue atrophy or depigmentation at injection site.

Precautions & Warnings

Kenalog should be used with caution in specific clinical situations and patient populations.

  • Assess infection risk: avoid use in active systemic infections.
  • Monitor glucose: patients with diabetes may need tighter glycemic control.
  • Evaluate bone health: prolonged therapy can affect bone mineral density.
  • Screen for ocular disease: consider ophthalmologic review for patients with glaucoma or cataracts.
  • Use lowest effective dose: limit frequency of intra‑articular injections.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Kenalog can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid)

  • Systemic CYP3A4 inhibitors (e.g., ketoconazole): may increase steroid exposure.
  • Live vaccines: risk of severe infection due to immunosuppression.
  • Anticoagulants (e.g., warfarin): may enhance bleeding risk.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive gastrointestinal irritation.
  • Diuretics: may exacerbate hypokalemia.
  • Antidiabetic agents: may require dose adjustment due to hyperglycemia.

Frequently Asked Questions

Kenalog (triamcinolone acetonide) is indicated for the treatment of inflammatory musculoskeletal disorders such as rheumatoid arthritis, osteoarthritis, bursitis, and tendinitis, as well as for severe allergic reactions and certain dermatologic inflammatory lesions when administered by injection.

Triamcinolone acetonide binds to glucocorticoid receptors inside cells, altering gene transcription to suppress pro‑inflammatory cytokines, inhibit phospholipase A2, and reduce leukocyte migration, thereby delivering potent anti‑inflammatory and immunosuppressive effects at the site of administration.

The dosage of Kenalog is determined by the prescribing clinician based on the specific indication, patient characteristics, and route of administration. The prescriber sets the appropriate strength, volume, and frequency for each individual case.

Safety of Kenalog in pregnancy or lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Kenalog, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Kenalog (triamcinolone acetonide) offers a high‑potency, long‑acting corticosteroid profile compared with agents like hydrocortisone or dexamethasone. Its formulation allows both intra‑articular and systemic use, providing flexibility for localized inflammation while maintaining strong anti‑inflammatory efficacy.

Kenalog should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keeping the product within this temperature range preserves its stability and potency.

Kenalog is administered by a qualified healthcare professional via intra‑articular injection into the affected joint, intramuscular injection, or intralesional injection for skin lesions, depending on the therapeutic indication.

Serious risks include severe allergic reactions (anaphylaxis), adrenal suppression, opportunistic infections, osteonecrosis of the jaw, and significant elevations in blood glucose or blood pressure. Patients should be monitored closely for these events during therapy.

Kenalog is contraindicated in patients with known hypersensitivity to triamcinolone acetonide or any component of the formulation, those with active systemic infections, and individuals receiving live vaccines. Caution is also advised for patients with uncontrolled diabetes, severe osteoporosis, or ocular diseases such as glaucoma.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Triamcinolone Acetonide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT